title: Effect of parenteral L-glutamine on muscle in the very severely ill.
abstract: Glutamine (Gln)-supplemented perioperative total parenteral nutrition (TPN) has been reported to reduce the loss of intramuscular glutamine following routine surgery. This study investigates whether glutamine-supplemented TPN can alter muscle biochemistry acutely in the very severely ill patient. Thirty-eight patients (age 19-77 yr; mean 55 yr), critically ill (APACHE II range 8-31; median 17) admitted to the intensive care unit (ICU) were recruited to receive either conventional TPN (CTPN) or an isonitrogenous, isoenergetic feed supplemented with 25 g crystalline L-glutamine per 24 h (GTPN) in a prospective, double blind, block-randomized study. In a representative sample of these patients, relatives consented to a paired muscle biopsy taken before feeding (10 GTPN/9 CTPN patients; ICU Day 2-4) and repeated 5 days later (16 patients; ICU Day 7-9). Muscle biopsies and matching plasma samples were analyzed using a coupled glutaminase-glutamate dehydrogenase enzymatic assay. A correction was made using sodium to account for the massive changes in extracellular fluid volume. The average muscle Gln content before feeding was very low. Between biopsies no consistent pattern of change was seen with or without exogenous Gln. It also proved difficult in these very sick patients to correct a low plasma Gln with L-Gln-TPN during the initial phase of the severe illness. TPN supplementation with 25 g/24 h, L-glutamine appears inadequate in the acute period to counteract the muscle and plasma biochemical changes seen in these patients. It is unknown whether any larger dose could alter this state.
authors.affiliation: Department of Medicine, University of Liverpool, UK.
authors.forename: T E
authors.initials: TE
authors.lastname: Palmer
authors.forename: R D
authors.initials: RD
authors.lastname: Griffiths
authors.forename: C
authors.initials: C
authors.lastname: Jones
mesh_terms: D000328:Adult; D000368:Aged; D001706:Biopsy; D015331:Cohort Studies; D016638:Critical Illness / Q000628:therapy*; D004311:Double-Blind Method; D005973:Glutamine / Q000008:administration & dosage* / Q000097:blood / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D009132:Muscles / Q000737:chemistry* / Q000378:metabolism; D010289:Parenteral Nutrition, Total; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D005973:Glutamine